Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers, Exosomes & Liquid Biopsy Asia 2019

Jan Lötvall's Biography

Jan Lötvall, Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

Jan Lötvall is Professor at the Institute of Medicine at Göteborg University since 2002 where he directs a research laboratory studying extracellular vesicles. He is a medical specialist in both Clinical Allergy and Clinical Pharmacology, and has a long-term experience in translational studies in primarily inflammation, but also cancer. He was first elected President of the International Society for Extracellular Vesicles (ISEV, 2011-2016), a rapidly growing non-profit organisation in the field of exosomes, microvesicles and other extracellular vesicles (; >1100 members). The research line focusing on extracellular vesicle biology has received extensive international recognition, as the lab was first to discover the ability of exosomes to shuttle RNA between cells in 2007. During the period of May 2016 to January 2018, JL served as Chief Scientist at Codiak BioSciences, a startup biotech company focusing on developing exosomes as a therapeutic platform. From January 2018, JL was the founding editor of the journals “Clinical and Translational Allergy” (2011, IF 3.239) and Journal of Extracellular Vesicles (JEV: IF 14.9). JL is the current Editor-in-Chief of JEV since August 2019. He is also the Chief Executive Officer and Chief Scientific Officer of Exocure Biosciences, a privately held vesicle therapeutics company.

Jan Lötvall Image

Emerging Applications of Extracellular Vesicles in Medicine

Monday, 9 September 2019 at 09:00

Add to Calendar ▼2019-09-09 09:00:002019-09-09 10:00:00Europe/LondonEmerging Applications of Extracellular Vesicles in MedicineCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul,

Extracellular vesicles (EVs) are released by all cells in the human body, and can reflect the status and function of the releasing cell. Further, EVs can shuttle cargo molecules from one cell to another, including proteins and RNA. The human body is exceptionally rich in EVs, and it has over the last ten years been acknowledge that the phenotype of these vesicles change in disease, and that EVs indeed can be utilized for diagnostic purposes, for example in cancer. Further, the functionality of EVs can in multiple ways be harnessed for the development of future biological medications. This presentation will discuss the diversity of EVs isolated from human tissues, and will also touch upon the opportunities of developing EVs as powerful therapeutics.

Add to Calendar ▼2019-09-09 00:00:002019-09-10 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019Circulating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul,